Subscribe
T. Schneider / Shutterstock.com
25 March 2025NewsAmericasMarisa Woutersen

Genmab fights claim over 'secrets theft' behind $1.8bn takeover

Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees helped ProfoundBio use confidential tech to improve its cancer treatment pipeline ahead of Genmab acquisition.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue
20 March 2025   Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.


Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025

Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025
Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

More on this story

Americas
Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue
20 March 2025   Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.

More on this story

Americas
Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue
20 March 2025   Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.

More features

Fed Circ affirms generic’s litigation costs of $12m are tax-deductible
European court upholds 10x patent after Nanostring appealed injunction
Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue
Verily, IBM, litigation funder on the art of leveraging patents
Tempus sues competitor over AI cancer diagnostic tech
Trouble at the USPTO—Part II: Bracing for impact
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
Trump chooses crypto-focused litigation funding expert to lead USPTO